Legal Opinion
Watson Pharmaceuticals, Inc. v. Henney
District Court, D. Maryland
Decided January 18, 2001No. 00CV3516PublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OPINION
SMALKIN, District Judge.
In an attempt to balance the national and private interests competing in the arena of patented pharmaceuticals, Congress some time ago enacted the so-called “Hatch-Waxman Amendments,” establishing a split-the-baby scheme under which holders of patents on “pioneer drugs” were extended the carrot of what amounts to extended patent protection to account for delays in FDA approval of a “pioneer drug,” in exchange for being whipped with the stick of an expedited, coat-tail procedure for FDA approval of competing, generic equivalents of the patented…
2Cases cited10 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Blackwelder Furniture Company of Statesville, Inc. v. Seilig Manufacturing Company, Inc.Court of Appeals for the Fourth Circuit · 1977
- Tri-Bio Laboratories, Inc. v. United States of America and Food and Drug AdministrationCourt of Appeals for the Third Circuit · 1988
- Securities and Exchange Commission v. GrayeDistrict Court, S.D. New York · 1957
5 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- In Re Buspirone Patent LitigationDistrict Court, S.D. New York · 2002
- Purepac Pharmaceutical Co. v. ThompsonDistrict Court, District of Columbia · 2002
- Andrx Pharmaceuticals, Inc. v. Biovail Corp.Court of Appeals for the Federal Circuit · 2002
- In Re Buspirone Patent LitigationDistrict Court, S.D. New York · 2002
- Alphapharm Pty Ltd. v. ThompsonDistrict Court, District of Columbia · 2004
1 more not listed; retrieve them via the Exa API.